郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration.

期刊：Cell discovery发表年份：2022作者：Huan Ma; Xinghai Zhang; Weihong Zeng; Junhui Zhou; Xiangyang Chi; Shaohong Chen; Peiyi Zheng; Meihua Wang; Yan Wu; Dan Zhao; Fanwu Gong; Haofeng Lin; Hancong Sun; Changming Yu; Zhengli Shi; Xiaowen Hu; Huajun Zhang; Tengchuan Jin; Sandra Chiu
阅读更多 →

病毒感染Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.

期刊：Emerging microbes & infections发表年份：2022作者：Hanjun Zhao; Xinjie Meng; Zheng Peng; Hoiyan Lam; Chuyuan Zhang; Xinxin Zhou; Jasper Fuk-Woo Chan; Richard Yi Tsun Kao; Kelvin Kai-Wang To; Kwok-Yung Yuen
阅读更多 →

病毒感染Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.

期刊：bioRxiv : the preprint server for biology发表年份：2022作者：Ashley C Beavis; Zhuo Li; Kelsey Briggs; María Cristina Huertas-Díaz; Elizabeth R Wrobel; Maria Najera; Dong An; Nichole Orr-Burks; Jackelyn Murray; Preetish Patil; Jiachen Huang; Jarrod Mousa; Linhui Hao; Tien-Ying Hsiang; Michael Gale; Stephen B Ha
阅读更多 →

病毒感染Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants.

期刊：Biosafety and health发表年份：2022作者：Zhe Ding; Tong Chen; Jiaming Lan; Gary Wong
阅读更多 →